Health Condition 1: K668- Other specified disorders of peritoneum
Conditions
Interventions
Intervention1: BA: NA
Control Intervention1: NA: NA
Sponsors
Tata Memorial Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1. Adult Patient (more than 18 years) 2. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) for peritoneal metastasis of gastro-intestinal and gynecologocal malignancies or primary peritoneal malignancies
Exclusion criteria
Exclusion criteria: 1) Patients on mechanical ventilation till POD 4 2) Incomplete data collection in CRS-HIPEC data base and Acute Pain Service data base.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Correlation of PCI scoring and worst pain score in postoperative periodTimepoint: Within 96 hours after surgery. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Total number of days under acute pain service (APS) surveillance 2. Analgesic modalities used in post-operative period (under active APS surveillance) 3. Pain Scores at rest and on movement in this period. 4. Incidence of coagulopathy 5. Re-referrals to APS/pain clinic after 96 hours period upto discharge. 6. Referrals to pain clinic and pain scores within 6 months after discharge Timepoint: From day of surgery upto 6 months after surgery | — |
Countries
India
Contacts
Public ContactDR KIRAN TANDLE
Tata Memorial Hospital, Mumbai
Outcome results
None listed